Table 2 Lymphoma type, sites of primary disease, intraorbital disease appearance, and sites of neurolymphomatosis involvement in patients with neurolymphomatosis in the orbit associated with lymphoma
Patient | Lymphoma type | Site(s) of primary disease | orbital /periorbital disease appearance | Site(s) of NL involvementa |
|---|---|---|---|---|
1 | DLBCL | Maxillary sinus | Spread to V2 | V2, PPF |
2 | DLBCL | Face | Spread to V2 | V2, PPF |
3 | DLBCL | Masticator space, neck | Spread to PPF | V2, V3, PPF, CS, MC |
4 | DLBCL | Face | Spread to V2 | V2 |
5 | DLBCL | Orbital/ | Mass involving lacrimal gland, face, and lateral orbit | V2, PPF, VC |
face | ||||
6 | DLBCL | Maxillary sinus/ | Maxillary sinus mass with spread to orbit | V2, PPF, VC |
orbit | ||||
7 | DLBCL | Orbit, neck, and chest wall | Orbital mass | V2, PPF |
8 | DLBCL | Forehead/eyebrow | Spread to V1 | V1 |
9 | DLBCL | Face | Spread to V2 | V2, PPF, CS, MC |
10 | Marginal zone | Orbit | Lacrimal gland and posterior orbital mass | II, V1, V2, PPF, CS, MC |
11 | Marginal zone | Orbit, skull base | Infiltrative disease involving orbit and extraocular muscles | II, V1, V2, PPF, CS, VC, MC |
12 | Marginal zone | Orbit | mass posterior orbit | II, V2, V3, PPF, CS |
13 | Low-grade B-cell | Masticator space, sphenoid bone, orbit | Masticator mass with spread to orbit | V2, PPF, CS |
14 | Low-grade B-cell | Orbit, nasopharynx, neck | Posterior orbital mass | V1, V2, V3, PPF, CS, VC |
15 | Mantle cell | Neck and chest | CN involvement | II, V2, PPF |
16 | Mantle cell | Chest node | CN involvement | V2, V3, PPF, MC |
17 | CLL/SLL | Abdomen | CN involvement | V1, V2, PPF, CS |
18 | NK/T-cell | Orbit, face, nasal cavity, nasopharynx | Infiltrative disease involving nasal cavity and orbit | V2, V3, VII, PPF, CS, MC |